SCORE

NAN

AKCA: Akcea Therapeutics is a Buy

AAPL chart by TradingView

The current rating for AKCA is NAN, which is -100% above its historic median rating of 50. This indicates lower risk than normal.

The rating is currently showing a higher than normal reading, suggesting risk levels could be lower than normal.